Arthur Herbst to Adenocarcinoma, Clear Cell
This is a "connection" page, showing publications Arthur Herbst has written about Adenocarcinoma, Clear Cell.
Connection Strength
2.297
-
Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
Score: 0.621
-
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
Score: 0.587
-
Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):814-20.
Score: 0.179
-
Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000 Feb; 76(2):147-56.
Score: 0.175
-
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999 Dec; 181(6):1574-5.
Score: 0.173
-
Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999 Dec; 181(6):1576-8; discussion 1579.
Score: 0.173
-
Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol. 1994 Nov; 55(2):238-44.
Score: 0.122
-
DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
Score: 0.122
-
Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
Score: 0.120
-
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011 Oct 06; 365(14):1304-14.
Score: 0.025